From: Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation
Outcome
Donepezil
Memantine
Difference
MMSE (0-30)
1.16
0.48
-0.68
NPI (0-144)
-2.40
-2.76
-0.36
Function (0-100)
-4.44
-2.35
2.09
Relative Risk of Drop-Out
1.18
0.66
0.62